Clinical Trial Update: The Impact of Intraoperative Methadone on Postoperative Opioid Use [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating intraoperative methadone to reduce postoperative opioid use in breast cancer patients has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Methadone (methadone)

Snippet

Sponsor: University of Utah | Conditions: Breast Cancer, Opioid Use | Phase 3 | Status: WITHDRAWN